FDA’s Generics Office Loses Another Director As Geba Makes Quick Exit
This article was originally published in The Pink Sheet Daily
Executive Summary
Gregory Geba will step down March 15, saying ongoing organizational changes created challenges to implementing his vision; CDER Director Janet Woodcock will run the office during the nationwide search for a replacement.